Search Results - "theis, D."

Refine Results
  1. 1
  2. 2

    Efficacy and safety of fumaric acid esters in young patients aged 10–17 years with moderate‐to‐severe plaque psoriasis: a randomized, double‐blinded, placebo‐controlled trial by Hamm, H., Wilsmann‐Theis, D., Tsianakas, A., Gambichler, T., Taipale, K., Lauterbach, J., Freudensprung, U., Makepeace, C.

    Published in British journal of dermatology (1951) (01-07-2021)
    “…Summary Background Apart from biologics, no systemic drugs are approved in Europe for children with moderate‐to‐severe psoriasis. Retrospective observational…”
    Get full text
    Journal Article
  3. 3

    Prevalence, predictors and comorbidity of dry skin in the general population by Augustin, M., Kirsten, N., Körber, A., Wilsmann‐Theis, D., Itschert, G., Staubach‐Renz, P., Maul, J‐T., Zander, N.

    “…Background Dry skin is a frequent and multifaceted condition which can be associated with skin irritation, itch, patient discomfort and manifest skin disease…”
    Get full text
    Journal Article
  4. 4

    Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics by Vrana, Julie A, Theis, Jason D, Dasari, Surendra, Mereuta, Oana M, Dispenzieri, Angela, Zeldenrust, Steven R, Gertz, Morie A, Kurtin, Paul J, Grogg, Karen L, Dogan, Ahmet

    Published in Haematologica (Roma) (01-07-2014)
    “…Examination of abdominal subcutaneous fat aspirates is a practical, sensitive and specific method for the diagnosis of systemic amyloidosis. Here we describe…”
    Get full text
    Journal Article
  5. 5

    Amyloid Typing by Mass Spectrometry in Clinical Practice: a Comprehensive Review of 16,175 Samples by Dasari, Surendra, Theis, Jason D., Vrana, Julie A., Rech, Karen L., Dao, Linda N., Howard, Matthew T., Dispenzieri, Angela, Gertz, Morie A., Hasadsri, Linda, Highsmith, W. Edward, Kurtin, Paul J., McPhail, Ellen D.

    Published in Mayo Clinic proceedings (01-09-2020)
    “…To map the occurrence of amyloid types in a large clinical cohort using mass spectrometry-based shotgun proteomics, an unbiased method that unambiguously…”
    Get full text
    Journal Article
  6. 6

    Classification of amyloidosis by laser microdissection and mass spectrometry–based proteomic analysis in clinical biopsy specimens by Vrana, Julie A., Gamez, Jeffrey D., Madden, Benjamin J., Theis, Jason D., Bergen Robert, H., Dogan, Ahmet

    Published in Blood (03-12-2009)
    “…The clinical management of amyloidosis is based on the treatment of the underlying etiology, and accurate identification of the protein causing the amyloidosis…”
    Get full text
    Journal Article
  7. 7

    A multicentre open‐label study of apremilast in palmoplantar pustulosis (APLANTUS) by Wilsmann‐Theis, D., Kromer, C., Gerdes, S., Linker, C., Magnolo, N., Sabat, R., Reich, K., Mössner, R.

    “…Background Palmoplantar pustulosis (PPP) is a chronic skin disease with painful erythematous scaly or crusty lesions and pustules on the palms and soles…”
    Get full text
    Journal Article
  8. 8

    Among the S100 proteins, S100A12 is the most significant marker for psoriasis disease activity by Wilsmann-Theis, D., Wagenpfeil, J., Holzinger, D., Roth, J., Koch, S., Schnautz, S., Bieber, T., Wenzel, J.

    “…Background Psoriasis is a chronic skin disease with deregulation of proteins in the immune system. These proteins include members of the heterogeneous S100…”
    Get full text
    Journal Article
  9. 9

    C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up by Sethi, Sanjeev, Fervenza, Fernando C, Zhang, Yuzhou, Zand, Ladan, Vrana, Julie A, Nasr, Samih H, Theis, Jason D, Dogan, Ahmet, Smith, Richard J H

    Published in Kidney international (01-08-2012)
    “…C3 glomerulonephritis (C3GN) is a recently described disorder that typically results from abnormalities in the alternative pathway (AP) of complement. Here, we…”
    Get more information
    Journal Article
  10. 10

    Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry by Kourelis, Taxiarchis V., Dasari, Surendra, Theis, Jason D., Ramirez-Alvarado, Marina, Kurtin, Paul J., Gertz, Morie A., Zeldenrust, Steven R., Zenka, Roman M., Dogan, Ahmet, Dispenzieri, Angela

    Published in Blood (19-01-2017)
    “…The goal of this study was to investigate the frequency of use of light-chain variable region (IGVL) genes among patients with systemic (ALS) and localized…”
    Get full text
    Journal Article
  11. 11

    DnaJ Heat Shock Protein Family B Member 9 Is a Novel Biomarker for Fibrillary GN by Dasari, Surendra, Alexander, Mariam P, Vrana, Julie A, Theis, Jason D, Mills, John R, Negron, Vivian, Sethi, Sanjeev, Dispenzieri, Angela, Highsmith, Jr, W Edward, Nasr, Samih H, Kurtin, Paul J

    “…Fibrillary GN (FGN) is a rare primary glomerular disease. Histologic and histochemical features of FGN overlap with those of other glomerular diseases, and no…”
    Get full text
    Journal Article
  12. 12

    A comparison of immunohistochemistry and mass spectrometry for determining the amyloid fibril protein from formalin-fixed biopsy tissue by Gilbertson, Janet A, Theis, Jason D, Vrana, Julie A, Lachmann, Helen, Wechalekar, Ashutosh, Whelan, Carol, Hawkins, Philip N, Dogan, Ahmet, Gillmore, Julian D

    Published in Journal of clinical pathology (01-04-2015)
    “…Amyloidosis is caused by deposition in tissues of abnormal protein in a characteristic fibrillar form. There are many types of amyloidosis, classified…”
    Get more information
    Journal Article
  13. 13

    Renal Amyloidosis: Origin and Clinicopathologic Correlations of 474 Recent Cases by Said, Samar M, Sethi, Sanjeev, Valeri, Anthony M, Leung, Nelson, Cornell, Lynn D, Fidler, Mary E, Herrera Hernandez, Loren, Vrana, Julie A, Theis, Jason D, Quint, Patrick S, Dogan, Ahmet, Nasr, Samih H

    “…The kidney is the organ most commonly involved in systemic amyloidosis. This study reports the largest clinicopathologic series of renal amyloidosis. This…”
    Get full text
    Journal Article
  14. 14

    Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis by Sethi, Sanjeev, Vrana, Julie A, Theis, Jason D, Leung, Nelson, Sethi, Anjali, Nasr, Samih H, Fervenza, Fernando C, Cornell, Lynn D, Fidler, Mary E, Dogan, Ahmet

    Published in Kidney international (01-07-2012)
    “…Accurate diagnosis and typing of renal amyloidosis is critical for prognosis, genetic counseling, and treatment. Laser microdissection and mass spectrometry…”
    Get more information
    Journal Article
  15. 15

    Changing within the same class: efficacy of brodalumab in plaque psoriasis after treatment with an IL-17A blocker - a retrospective multicenter study by Kromer, C, Wilsmann-Theis, D, Gerdes, S, Krebs, S, Pinter, A, Philipp, S, Mössner, R

    Published in The Journal of dermatological treatment (01-12-2021)
    “…Biologic switching is common in psoriasis patients with non-response to or adverse events under therapy with a biologic. However, evidence on efficacy of…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Immunotactoid glomerulopathy: clinicopathologic and proteomic study by NASR, Samih H, FIDLER, Mary E, SETHI, Sanjeev, CORNELL, Lynn D, LEUNG, Nelson, COSIO, Fernando G, SHEIKH, Salwa S, AMIR, Abdulrazack A, VRANA, Julie A, THEIS, Jason D, DOGAN, Ahmet

    Published in Nephrology, dialysis, transplantation (01-11-2012)
    “…Immunotactoid glomerulopathy (ITG) is a rare glomerular disease. Here, we report the largest clinicopathologic series of ITG and define its proteomic profile…”
    Get full text
    Journal Article
  20. 20

    Characterization of C3 in C3 glomerulopathy by Sethi, Sanjeev, Vrana, Julie A, Fervenza, Fernando C, Theis, Jason D, Sethi, Amit, Kurtin, Paul J, Zhang, Yuzhou, Smith, Richard J H

    Published in Nephrology, dialysis, transplantation (01-03-2017)
    “…C3 glomerulopathy (C3G) is caused by overactivity of the alternative pathway of complement that results in bright glomerular C3 staining with minimal or no…”
    Get full text
    Journal Article